Your browser doesn't support javascript.
loading
National Hospital and Health-System Controlled Substances Drug Diversion Prevention & Surveillance Program Assessment Survey - 2021.
Fortier, Christopher R.
Affiliation
  • Fortier CR; Nephron Pharmaceuticals Corporation, West Columbia, SC, USA.
Am J Health Syst Pharm ; 81(4): 137-145, 2024 Feb 08.
Article in En | MEDLINE | ID: mdl-37756623
ABSTRACT

PURPOSE:

To present and discuss the results of the National Hospital and Health-System Controlled Substances Drug Diversion Prevention & Surveillance Program Assessment Survey.

METHODS:

The survey was emailed to 1,529 chief pharmacy officers utilizing the list of directors of pharmacy from the American Society of Health-System Pharmacists. The survey opened September 15, 2021, and closed October 4, 2021. Forty-nine questions were included in 5 different sections, and participants were also given the option to respond to 39 additional questions.

RESULTS:

The survey response rate was 12.75%, with the results showing consistencies in practice around drug security and human resource management. Sixty-two percent of sites had a formalized drug diversion committee, half of which had been implemented since 2018. Adoption of electronic controlled substance systems continues to increase, with 50% of sites having implemented such a system in the previous 3 years. At the time of the survey, 18% of organizations did not have an electronic system, but 90% of sites had implemented or intended to implement one by 2023. Over 40% of sites that utilized an electronic system were looking to upgrade to a next-generation system. Most organizations had 0.5 to 1 full-time equivalent dedicated to diversion prevention, and two-thirds of sites had a formalized diversion committee. The majority of sites defined "significant loss" by utilizing professional judgement, based on the scenario, as a percentage of inventory or as a range of units. Community practice consensus is needed around auditing adjustments to controlled substance inventory and for perpetual inventory processes. Respondents reported 1 to 2 (29%), 3 to 5 (26%), and more than 10 (26%) formal drug diversion investigations annually.

CONCLUSION:

This first-time survey provided significant insight into the realities of drug diversion prevention practices in hospitals and health systems nationally.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pharmacy Service, Hospital / Controlled Substances Type of study: Screening_studies Limits: Humans Country/Region as subject: America do norte Language: En Journal: Am J Health Syst Pharm Year: 2024 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pharmacy Service, Hospital / Controlled Substances Type of study: Screening_studies Limits: Humans Country/Region as subject: America do norte Language: En Journal: Am J Health Syst Pharm Year: 2024 Document type: Article